[Comparison between continuous epidural instillation of ropivacaine and bupivacaine in patients with lung cancer].
We compared the efficiency of continuous epidural analgesia with ropivacaine and bupivacaine in patients with lung carcinoma stages IIIB and IV. We studied 25 patients aged 48-70 years, divided in two groups A (13 patients) and B (12 patients). Group A received continuous epidural infusion with ropivacaine 0.2%, 6 ml/h and group B received continuous epidural infusion with bupivacaine 0.2%, 6 ml/h. Pain level, neuromuscular block intensity and PONV incidence were similar in both groups during the first 72 hours. The ropivacaine group needed more nonopioid analgesic (Dinastat).
Nicolcescu
P
P
Disciplina A.T.I, U.M.F. Craiova.
Bădulescu
Fl
F
Schenker
Michael
M
D000368:Aged; D000577:Amides / Q000627:therapeutic use*; D015360:Analgesia, Epidural; D000779:Anesthetics, Local / Q000627:therapeutic use*; D002045:Bupivacaine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007322:Instillation, Drug; D008175:Lung Neoplasms / Q000150:complications* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010147:Pain Measurement; D010166:Palliative Care; D000077212:Ropivacaine
D000577:Amides; D000779:Anesthetics, Local; D000077212:Ropivacaine; D002045:Bupivacaine